Skip to main content

Par C210 (Fenofibric Acid Delayed-Release 135 mg)

Pill with imprint Par C210 is Blue & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Par Pharmaceutical Companies, Inc.

Fenofibric acid is used in the treatment of high cholesterol; hypertriglyceridemia and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Par C210

Fenofibric acid delayed-release 135 mg Par C210

Fenofibric Acid Delayed-Release

Imprint
Par C210
Strength
135 mg
Color
Blue & Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical Companies, Inc.
Inactive Ingredients
lactose monohydrate, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, stearic acid, magnesium silicate, triethyl citrate, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, D&C Yellow No. 10, ferrosoferric oxide, propylene glycol, shellac, FD&C Yellow No. 6, gelatin, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
10370-0210 (Discontinued) Anchen Pharmaceuticals, Inc.
68084-0715 (Discontinued) Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.